Toxic epidermal necrolysis possibly linked to hyperacute graft-versus- host disease after allogeneic bone marrow transplantation

Journal of Dermatology

Volumn 24, Issue 10, 1997, Pages 635-641

  Takeda, Hikaru ^a   Mitsuhashi, Yoshihiko ^a   Kondo, Shigeo ^a   Kato, Yu Ichi ^a   Tajima, Katsufumi ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Adverse drug reaction; Bone marrow transplantation; GVHD; Hyperacute; Leukemia

Indexed keywords

ACICLOVIR; AMIKACIN; AMPHOTERICIN B; BILIRUBIN; CEFOTIAM; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIPYRONE; ETOPOSIDE; FLUCONAZOLE; FUROSEMIDE; HYDROXYZINE; ISOSORBIDE; MESNA; METHOTREXATE; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MORPHINE; ONDANSETRON; PANIPENEM PLUS BETAMIPRON; PENTAZOCINE; PIPERACILLIN; PIRENZEPINE; POLYMYXIN B; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SULPIRIDE; VANCOMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; MALE; SIDE EFFECT; SKIN BIOPSY; TOXIC EPIDERMAL NECROLYSIS; WHOLE BODY RADIATION;

EID: 0030694470     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1997.tb02308.x     Document Type: Article

References (32)

1. Fritsch PO, Elias PM, Hinter H: Erythema multifome and toxic epidermal necrolysis, in Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF (eds): Dermatology in General Medicine, McGraw-Hill, New York, 1993, pp 596-599.
2. Peck GL, Herzig GP, Elias PM: Toxic epidermal necrolysis in a patient with graft-vs-host reaction, Arch Dermatol, 105: 561-169, 1972.
3. Graw RG, Herzig GP, Rogentine GN Jr, et al: Graft-vs-host reaction complicating HLA-matched bone marrow transplantation, Lancet, 2: 1053-1055, 1970.
4. Ammann AJ, Tooley WH, Hong R: Toxic epidermal necrolysis, Lancet, 2: 484, 1972.
5. Peck GL, Elias PM, Graw RG: Graft-vs-host reaction and toxic epidermal necrolysis, Lancet, 2: 1151-1153, 1972.
6. Friedman HZ, Arias AM, Catchatourian R, et al: Toxic epidermal necrolysis following bone marrow transplantation, Cutis, 34: 158-162, 1984.
7. McDonald BJ, Singer JW, Bianco JA: Toxic epidermal necrolysis possibly linked to aztreonam in bone marrow transplant patients, Ann Pharmacother, 26: 34-35, 1992.
8. Villada G, Roujeau J-C, Cordonnier C, et al: Toxic epidermal necrolysis after bone marrow transplantation: Study of nine cases, J Am Acad Dermatol, 23: 870-875, 1990.
9. Thomas ED, Storb R, Clift RA, et al: Bone marrow transplantation, New Eng J Med, 292: 832-843, 895-902, 1975.
10. Sullivan KM, Deeg HJ, Sanders J, et al: Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic bone marrow transplantation, Blood, 67: 1172-1175, 1986.
11. Imamura M, Hashino S, Kobayashi S, et al: Hyperacute graft-versus-host disease accompanied by increased serum interleukin-6 levels, Int J Hematol, 60: 85-89, 1994.
12. Sullivan KM, Rainer S, Witherspoon RP, et al: Deletion of immunosupressive prophylaxis after marrow transplantation increases hyperacute graft-versus-host disease but does not influence chronic graft-versus-host disease or relapse in patients with advanced leukemia, Clin Transplantation, 3: 5-11, 1989.
13. Sandmaier BM, Storb R, Santos EB, et al: Allogeneic transplants of canine peripheral blood stem cells morbilized by recombinant canine hematopoietic growth factors, Blood, 87: 3358-3513, 1996.
14. Lu DP, Guo NL, Jin NR, et al: Allogeneic bone marrow transplantation for the treatment of leukemia, Chin Med J, 103: 125-130, 1990.
15. Dalal DI, Stockford GR, Naiman SC, et al: Criteria for marrow engraftment: Comparison of reticulocyte maturity index with conventional parameters, Bone Marrow Transplant, 17: 91-92, 1996.
16. Kernan N, Collins NH, Juliano L, et al: Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-versus-host disease, Blood, 68: 770-773, 1986.
17. Xun C, Broun SA, Jennings D, et al: Acute graft-versus-host like disease induced by transplantation of human activated natural killer cells into scid mice, Transplant, 56: 409-417, 1993.
18. Holler E, Kolb HJ, Moller A, et al: Increased serum levels of tumor necrosis factor precede major complications of bone marrow transplantation, Blood, 75: 1011-1016, 1990.
19. Dickinson AM, Sviland L, Dunn J, et al: Demonstration of direct involvement of cytokines in graft-versus-host reactions using an in vitro skin explant model, Bone Marrow Transplant, 7: 209-216, 1991.
20. Symington FW, Symington BE, Liu PY, et al: The relationship of serum IL-6 levels to acute graft-versus-host disease and hepatorenal disease after human bone marrow transplantation, Transplant, 54: 457-462, 1992.
21. Gale RP, Bortin MM, van Beckum DW, et al: Risk factors for acute graft-versus-host disease, Br J Haematol, 67: 397, 1987.
22. Nash RA, Pepe MS, Storb R, et al: Acute graft-versus-host disease: Analysis of risk factor after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate, Blood, 80: 1838, 1992.
23. Antin JH, Ferrara JLM: Cytokine dysregulation and acute graft-versus-host disease, Blood, 80: 2969, 1992.
24. Appleton AL, Sviland L: Pathogenesis of GVHD: Role of herpes viruses, Bone Marrow Transplant, 11: 349, 1993.
25. Sale GE, Lerner KG, Baker EA, et al: The skin biopsy in the diagnosis of acute graft-versus-host disease in man, Am J Pathol, 89: 621-636, 1977.
26. Tanaka K, Tanaka A: Cutaneous manifestations and pathophysiology of hyperacutc graft-versus-host disease, Nishinihon J Dermatol, 54: 232-235, 1992.
27. Guillaume J-C, Roujeau J-C, Revuz J, et al: The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome), Arch Dermatol, 123: 1166-1170, 1987.
28. Moore N, Biour M, Paux G, et al: Adverse drug eruption monitoring: Doing it the French way, Lancet, 2: 1056-1058, 1985.
29. Roujeau JC, Kelly JP, Naldi L, et al: Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis, New Eng J Med, 14: 1600-1607, 1995.
30. Sale GE: Pathology and recent pathologic studies in human graft-versus-host disease, Surv Synth Path Res, 3: 235-253, 1984.
31. Carr A, Vasak E, Munro V, et al: Immunohistological assessment of cutaneous drug hypersensitivity in patients with HIV infection, Clin Exp Immunol, 97: 260-265, 1994.
32. Bayard PJ, Berger TG, Jacobson MA: Drug hypersensitivity reactions and human immunodeficiency virus disease, J Acq Immun Defic Syndr, 5: 1237-1257, 1992.